|
87
|
306
|
8u25A |
Crystal structure of sars-cov-2 main protease (mpro) l50f/e166a/l167f triple mutant |
|
81
|
298
|
8y4fA |
Crystal structure of hcov 229e main protease in complex with bofutrelvir |
|
82
|
304
|
8udxA |
Crystal structure of sars-cov-2 3cl protease with c145 sulfinic acid in complex with inhibitor 17 |
|
89
|
306
|
8tykA |
Crystal structure of sars-cov-2 main protease (mpro) t21i mutant |
|
91
|
302
|
8zt9A |
The crystal structure of mol066 bound to the main protease (3clpro/mpro) of sars-cov-2 |
|
91
|
301
|
8zubA |
The crystal structure of mol075 bound to the main protease (3clpro/mpro) of sars-cov-2 |
|
88
|
301
|
8zucA |
The crystal structure of mol080 bound to the main protease (3clpro/mpro) of sars-cov-2 |
|
90
|
301
|
8zucB |
The crystal structure of mol080 bound to the main protease (3clpro/mpro) of sars-cov-2 |
|
82
|
305
|
8wtsA |
Sars-cov-2 3clpro bound to covalent inhibitor |
|
79
|
304
|
9vs1A |
Crystal structure of sars-cov-2 3cl protease in complex with compound 15 |
|
88
|
305
|
9wheA |
A novel, covalent and highly synthetically accessible sars-cov-2 mpro chloroacetamide inhibitor |
|
89
|
305
|
9n3mA |
Sars-cov-2 mpro l50f/e166a/l167f triple mutant bound to inhibitor |
|
85
|
300
|
9ippA |
Crystal structure of mers main protease in complex with carmofur |
|
83
|
300
|
8intA |
Crystal structure of sars-cov-2 main protease (mpro) k90r mutant |
|
85
|
306
|
8inwA |
Crystal structure of sars-cov-2 main protease (mpro) k90r mutant in complex with inhibitor nirmatrelvir |
|
86
|
306
|
8inuA |
Crystal structure of sars-cov-2 main protease (mpro) g15s mutant in complex with inhibitor nirmatrelvir |
|
85
|
300
|
8inqA |
Crystal structure of sars-cov-2 main protease (mpro) g15s mutant |
|
84
|
301
|
8inxA |
Crystal structure of sars-cov-2 main protease (mpro) g15s mutant in complex with inhibitor ensitrelvir |
|
83
|
301
|
8inyA |
Crystal structure of sars-cov-2 main protease (mpro) k90r mutant in complex with inhibitor ensitrelvir |
|
81
|
300
|
8ya5A |
Mpro from sars-cov-2 |
|
93
|
305
|
8cdcA |
Native 3clpro from sars-cov-2 at 1.54 a |
|
92
|
306
|
8r11A |
Structure of compound 7 bound to sars-cov-2 main protease |
|
87
|
306
|
8r14A |
Structure of compound 11 bound to sars-cov-2 main protease |
|
88
|
306
|
8r16A |
Structure of compound 12 bound to sars-cov-2 main protease |
|
89
|
306
|
8r12A |
Structure of compound 8 bound to sars-cov-2 main protease |
|
84
|
301
|
7c7pA |
Crystal structure of the sars-cov-2 main protease in complex with telaprevir |
|
88
|
306
|
7rm2A |
Room temperature x-ray structure of sars-cov-2 main protease (mpro) in complex with mcule-csr-494190-s1 |
|
85
|
306
|
7rnkA |
Room temperature x-ray structure of sars-cov-2 main protease (mpro) in complex with hl-3-71 |
|
75
|
304
|
7mlgA |
Crystal structure of sars-cov-2 main protease (3clpro/mpro) covalently bound to compound c63 |
|
71
|
298
|
7draA |
Crystal structure of mers-cov 3cl protease (c148a) in spacegroup p212121,ph 9.0 |
|
86
|
306
|
7t3zA |
Structure of mers 3cl protease in complex with inhibitor 9c |
|
76
|
298
|
7dr9A |
Crystal structure of mers-cov 3cl protease (c148a) in spacegroup p212121 |
|
88
|
306
|
7dghA |
The co-crystal structure of sars-cov-2 main protease with peptidomimetic inhibitor n-((s)-3-methyl-1-(((s)-4-methyl-1-oxo-1-(((s)-1-oxo-3-((s)-2-oxopiperidin-3-yl)propan-2-yl)amino)pentan-2-yl)amino)-1-oxobutan-2-yl)-2-naphthamide |
|
74
|
304
|
7mlfA |
Crystal structure of sars-cov-2 main protease (3clpro/mpro) covalently bound to compound c7 |
|
82
|
301
|
7ddcA |
Crystal structure of sars-cov-2 main protease in complex with tafenoquine |
|
86
|
303
|
7dgfA |
The co-crystal structure of sars-cov-2 main protease with peptidomimetic inhibitor (s)-2-cinnamamido-n-((s)-1-oxo-3-((s)-2-oxopiperidin-3-yl)propan-2-yl)hexanamide |
|
85
|
303
|
7dgbA |
The co-crystal structure of sars-cov-2 main protease with (s)-2-cinnamamido-4-methyl-n-((s)-1-oxo-3-((s)-2-oxopyrrolidin-3-yl)propan-2-yl)pentanamide |
|
84
|
301
|
7dggA |
The co-crystal structure of sars-cov-2 main protease with (s)-2-cinnamamido-n-((s)-1-oxo-3-((s)-2-oxopyrrolidin-3-yl)propan-2-yl)hexanamide |
|
89
|
306
|
7dgiA |
The co-crystal structure of sars-cov-2 main protease with peptidomimetic inhibitor n-((s)-3-methyl-1-(((s)-4-methyl-1-oxo-1-(((s)-1-oxo-3-((s)-2-oxopiperidin-3-yl)propan-2-yl)amino)pentan-2-yl)amino)-1-oxobutan-2-yl)-4-nitrobenzamide |
|
84
|
299
|
7dr8A |
Crystal structure of mers-cov 3cl protease in spacegroup p212121 |
|
84
|
306
|
7vjzA |
Crystal structure of sars-cov-2 mpro at 1.90 a resolution-7 |
|
83
|
300
|
7vvtA |
Sars-cov-2 3cl protease (3clpro) in complex with a covalent inhibitor |
|
75
|
300
|
7vk6A |
Crystal structure of sars-cov-2 mpro at 2.25 a resolution-13 |
|
90
|
306
|
7vk1A |
Crystal structure of sars-cov-2 mpro at 1.93 a resolution-5 |
|
84
|
301
|
7vicA |
The crystal structure of sars-cov-2 3c-like protease in complex with a traditional chinese medicine inhibitors |
|
79
|
300
|
7vk7A |
Crystal structure of sars-cov-2 mpro at 2.4 a resolution-11 |
|
77
|
300
|
7vk4A |
Crystal structure of sars-cov-2 mpro at 2.10 a resolution-3 |
|
80
|
300
|
7vjwA |
Crystal structure of sars-cov-2 mpro at 2.20 a resolution-10 |
|
85
|
306
|
7rmeA |
Room temperature x-ray structure of sars-cov-2 main protease (mpro) in complex with hl-3-52 |
|
86
|
306
|
7rmbA |
Room temperature x-ray structure of sars-cov-2 main protease (mpro) in complex with hl-3-78 |
